Rajpaul Attariwala - Net Worth and Insider Trading
Rajpaul Attariwala Net Worth
The estimated net worth of Rajpaul Attariwala is at least $1,049 dollars as of 2024-09-21. Rajpaul Attariwala is the Director of Algernon Pharmaceuticals Inc and owns about 12,337 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $1,049. Details can be seen in Rajpaul Attariwala's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rajpaul Attariwala has not made any transactions after 2022-04-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rajpaul Attariwala
Rajpaul Attariwala Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rajpaul Attariwala owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .
Click here to see the complete history of Rajpaul Attariwala’s form 4 insider trades.
Insider Ownership Summary of Rajpaul Attariwala
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2022-04-12 | Director |
Rajpaul Attariwala Latest Holdings Summary
Rajpaul Attariwala currently owns a total of 1 stock. Rajpaul Attariwala owns 12,337 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of April 12, 2022, with a value of $1,049.
Latest Holdings of Rajpaul Attariwala
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2022-04-12 | 12,337 | 0.09 | 1,049 |
Holding Weightings of Rajpaul Attariwala
Rajpaul Attariwala Form 4 Trading Tracker
According to the SEC Form 4 filings, Rajpaul Attariwala has made a total of 1 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the acquisition of 900 shares on April 12, 2022, which cost Rajpaul Attariwala around $5,607.
Insider Trading History of Rajpaul Attariwala
- 1
Rajpaul Attariwala Trading Performance
GuruFocus tracks the stock performance after each of Rajpaul Attariwala's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rajpaul Attariwala is -46.45%. GuruFocus also compares Rajpaul Attariwala's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rajpaul Attariwala within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rajpaul Attariwala's insider trading performs compared to the benchmark.
Performance of Rajpaul Attariwala
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -20.99 | | | | | |
| Relative Return to S&P 500(%) | -10.36 | | | | | |
Rajpaul Attariwala Ownership Network
Rajpaul Attariwala Owned Company Details
What does Algernon Pharmaceuticals Inc do?
Who are the key executives at Algernon Pharmaceuticals Inc?
Rajpaul Attariwala is the Director of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Director & Senior Officer Christopher Moreau , Senior Officer Christopher Scott Bryan , and Senior Officer James Kinley .
Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary
Over the past 18 months, Rajpaul Attariwala made no insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN). Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 60,500 shares made by Christopher Scott Bryan , a net purchase of 52,500 shares made by Christopher Moreau , and a net purchase of 12,500 shares made by James Kinley .
In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 125,500 shares were bought by its insiders, resulting in a net purchase of 125,500 shares.
Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Algernon Pharmaceuticals Inc Insider Transactions
Rajpaul Attariwala Mailing Address
Above is the net worth, insider trading, and ownership report for Rajpaul Attariwala. Currently GuruFocus does not have mailing address information for Rajpaul Attariwala.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
